[
    [
        {
            "orginal_text": "泰格医药：关于公司副总经理、财务负责人兼董事会秘书辞职以及聘任公司财务负责人、董事会秘书及证券事务代表的公告\n董监高成员变化",
            "features": {
                "keywords": [
                    "泰格医药",
                    "副总经理",
                    "财务负责人",
                    "董事会秘书",
                    "辞职",
                    "聘任"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "泰格医药：关于公司副总经理、财务负责人兼董事会秘书辞职以及聘任公司财务负责人、董事会秘书及证券事务代表的公告\n董监高成员变化",
            "scores": {
                "News_content": "泰格医药：关于公司副总经理、财务负责人兼董事会秘书辞职以及聘任公司财务负责人、董事会秘书及证券事务代表的公告\n董监高成员变化",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "orginal_text": "泰格医药：吴灏获提名第四届董事会执行董事候选人",
            "features": {
                "keywords": [
                    "泰格医药",
                    "吴灏",
                    "第四届董事会",
                    "执行董事",
                    "候选人"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "泰格医药：吴灏获提名第四届董事会执行董事候选人",
            "scores": {
                "News_content": "泰格医药：吴灏获提名第四届董事会执行董事候选人",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "orginal_text": "泰格医药：董事会审议并通过修改公司章程等议案",
            "features": {
                "keywords": [
                    "泰格医药",
                    "董事会",
                    "修改公司章程",
                    "议案"
                ],
                "sentiment_score": 0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "泰格医药：董事会审议并通过修改公司章程等议案",
            "scores": {
                "News_content": "泰格医药：董事会审议并通过修改公司章程等议案",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "orginal_text": "泰格医药(3347.HK)：聘任曹晓春为公司财务负责人",
            "features": {
                "keywords": [
                    "泰格医药",
                    "曹晓春",
                    "财务负责人",
                    "聘任"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "泰格医药(3347.HK)：聘任曹晓春为公司财务负责人",
            "scores": {
                "News_content": "泰格医药(3347.HK)：聘任曹晓春为公司财务负责人",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "orginal_text": "泰格医药：Jun Gao辞去公司副总经理等职务",
            "features": {
                "keywords": [
                    "泰格医药",
                    "Jun Gao",
                    "副总经理",
                    "辞职"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "泰格医药：Jun Gao辞去公司副总经理等职务",
            "scores": {
                "News_content": "泰格医药：Jun Gao辞去公司副总经理等职务",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "orginal_text": "【权益变动】泰格医药(3347.HK)获摩根大通增持27.53万股",
            "features": {
                "keywords": [
                    "泰格医药",
                    "摩根大通",
                    "增持",
                    "权益变动"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【权益变动】泰格医药(3347.HK)获摩根大通增持27.53万股",
            "scores": {
                "News_content": "【权益变动】泰格医药(3347.HK)获摩根大通增持27.53万股",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "orginal_text": "泰格医药(300347.SZ)提名吴灏为董事候选人",
            "features": {
                "keywords": [
                    "泰格医药",
                    "吴灏",
                    "董事候选人",
                    "提名"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "泰格医药(300347.SZ)提名吴灏为董事候选人",
            "scores": {
                "News_content": "泰格医药(300347.SZ)提名吴灏为董事候选人",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "orginal_text": "泰格医药(300347.SZ)聘任曹晓春为财务负责人",
            "features": {
                "keywords": [
                    "泰格医药",
                    "曹晓春",
                    "财务负责人",
                    "聘任"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "泰格医药(300347.SZ)聘任曹晓春为财务负责人",
            "scores": {
                "News_content": "泰格医药(300347.SZ)聘任曹晓春为财务负责人",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "orginal_text": "泰格医药：Jun Gao（高峻）辞去公司副总经理、财务负责人兼董事会秘书职务 董监高成员变化",
            "features": {
                "keywords": [
                    "泰格医药",
                    "Jun Gao",
                    "高峻",
                    "副总经理",
                    "财务负责人",
                    "董事会秘书",
                    "辞职"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "泰格医药：Jun Gao（高峻）辞去公司副总经理、财务负责人兼董事会秘书职务 董监高成员变化",
            "scores": {
                "News_content": "泰格医药：Jun Gao（高峻）辞去公司副总经理、财务负责人兼董事会秘书职务 董监高成员变化",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "orginal_text": "医疗服务行业周报：创新药融资前景乐观 外包服务将持续受益",
            "features": {
                "keywords": [
                    "医疗服务",
                    "创新药",
                    "融资",
                    "外包服务",
                    "受益"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医疗服务行业周报：创新药融资前景乐观 外包服务将持续受益",
            "scores": {
                "News_content": "医疗服务行业周报：创新药融资前景乐观 外包服务将持续受益",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "orginal_text": "A股收盘综述：市场高抛煤、钢、稀土、锂，“吃药喝酒”局面再现或因基金纠正风格漂移",
            "features": {
                "keywords": [
                    "A股",
                    "收盘综述",
                    "煤炭",
                    "钢铁",
                    "稀土",
                    "锂",
                    "医药",
                    "白酒",
                    "基金",
                    "风格漂移"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "白酒",
                    "煤炭",
                    "钢铁",
                    "稀土",
                    "锂"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "original_text": "A股收盘综述：市场高抛煤、钢、稀土、锂，“吃药喝酒”局面再现或因基金纠正风格漂移",
            "scores": {
                "News_content": "A股收盘综述：市场高抛煤、钢、稀土、锂，“吃药喝酒”局面再现或因基金纠正风格漂移",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]